Source: Annual Congress 2004 - Targeting acute and chronic airway obstruction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. J. van Overveld, D. Gòrecka, U. A. Demkow, A. Nowinski, P. Bielen, D. Kaminski, E. Puscinska, A. Goljan, J. Kolakowski, W. A. De Backer, J. Zielinski (Antwerpen, Belgium; Warsaw, Poland). The effects of a crossover treatment with inhaled corticosteroids and N-acetylcysteine on lung function parameters in COPD-patients. Eur Respir J 2004; 24: Suppl. 48, 2155

Member's Comments

No comment yet.

Related content which might interest you: Treatment of COPD: comparing the effects of inhaled steroids with N-acetylcysteine Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004 The effects of addition montelukast to inhaled steroids in the regular treatment of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 262s Year: 2001 Effects of inhaled corticosteroids on asthmatic inflammation: The FeNOtype trial Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 The effect of combined β2-agonist and anticholinergic inhaled therapy in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004 The anti-tussive effects of an inhaled LABA are maintained after chronic treatment Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 The influence of high doses of N-acetylcysteine alone or in combination with inhaled corticosteroids on quality of life in patients with COPD Source: Annual Congress 2011 - COPD management Year: 2011 Anti-inflammatory effect and clinical efficacy of concomitant treatments to steroid inhaler in bronchial asthma: montelukast versus salmeterol Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006 Effects of adding salmeterol to inhaled corticosteroids on lung function and quality of life in patients with mild persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006 Effects of treatment with N-acetylcysteine or inhaled corticosteroids on inflammatory mediators in COPD-patients Source: Eur Respir J 2003; 22: Suppl. 45, 5s Year: 2003 Cardioprotective effects of inhaled corticosteroid-containing combination therapy in COPD Source: Eur Respir J, 53 (2) 1802420; 10.1183/13993003.02420-2018 Year: 2019 Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients Source: Annual Congress 2010 - COPD: management Year: 2010 Inhaled mannitol improves lung function assessed by forced oscillation in a placebo controlled trial in patients with bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 470s Year: 2004 The effects of adding in erdosteine on the routine bronchodilator therapy in moderate and severe COPD patients Source: Annual Congress 2006 - COPD therapy Year: 2006 Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 High doses of N-acetylcysteine alone or in combination with inhaled corticosteroids and oxidative stress in patients with COPD Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Protective effect of inhaled glucocorticosteroids on COPD model. Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Effects of low dose inhaled theophylline (ADC4022) co-administered with budesonide on inflammatory markers, lung function, and quality of life in COPD patients Source: Annual Congress 2009 - New drugs for airways disease Year: 2009